Rocket Lab's Real Growth Story Isn't Neutron

Rocket Lab reported Q4 revenue of $180M (+36% YoY) and record 38% GAAP gross margins, driving full-year revenue to $602M. Backlog stands at $1.85B with 37% expected to convert in 12 months (implying roughly $685M revenue visibility), and more than $1.3B in SDA defense contracts for missile-tracking constellations is supporting near-term growth and visibility.

Analysis

Rocket Lab’s results should be read as an inflection in cash-generative program work rather than a pure consumer-scale growth story; that shifts the competitive map toward suppliers of spacecraft buses, mission integration services, and ground systems who now become the recurring-margin beneficiaries. The company’s improving unit economics give it leverage in contract negotiations with primes and governments, which will pressure less vertically integrated small-launch peers to either consolidate or specialize into niche services.

The biggest operational tail risks sit at the program execution layer: supplier lead-times for avionics/propulsion, margins tied to milestone billing cadence, and the typical defense-contract cliff where one delayed prototype delivery can push multi-quarter revenue forward. Near-term market moves will be driven by execution updates (launch cadence, SDA milestones) within weeks-to-months, while true earnings visibility and margin sustainability play out over 12–36 months as constellations are manufactured and launched.

For the wider market, expect second-order effects across insurance, launch-vehicle manufacturers, and geospatial analytics firms: cheaper, reliable launches accelerate constellation deployments that compress satellite component costs but also raise the bar for ground-segment scalability. On the flip side, primes with legacy vertically integrated models face margin pressure and could opportunistically outsource more, creating acquisition targets and M&A optionality in the next 6–24 months.

Key Decisions for Investors

• Long RKLB (equity) with a 12–18 month horizon: entry on any >8% pullback post-earnings; target 2.5x upside if launch cadence and SDA milestone cadence are met, stop-loss at 25% below entry to limit execution risk.
• Buy AJRD (Aerojet Rocketdyne) or LHX (L3Harris) to play propulsion and avionics tailwinds: 6–12 month hold, expect steady bid for suppliers as primes outsource; hedge 25% of position with short-dated puts if launch-failure headlines spike volatility.
• Pair trade: long RKLB / short a lightly funded small-launch peer (select based on liquidity) to isolate execution-on-contract exposure versus pure speculative volume bets; target asymmetric payoff where RKLB captures defense revenue conversion while the peer is penalized for missed cadence.
• Options: buy 12–18 month RKLB LEAP calls sized for 2–3x leverage rather than margin purchases—this captures program upside while limiting downside to premium; sell near-term calls against the position if you need to finance premium and expect short-term volatility to compress IV.
• Monitor catalysts (alerts): any SDA milestone delays, a failed launch, or supplier insolvency — trim 30–50% on the first material negative event; conversely, accelerate sizing if the company confirms multi-quarter launch schedule and steady gross-margin hold.